Interplay between aging and other factors of the pathogenesis of age-related macular degeneration

Ageing Res Rev. 2022 Nov:81:101735. doi: 10.1016/j.arr.2022.101735. Epub 2022 Sep 13.

Abstract

Age-related macular degeneration (AMD) is a complex eye disease with the retina as the target tissue and aging as per definition the most serious risk factor. However, the retina contains over 60 kinds of cells that form different structures, including the neuroretina and retinal pigment epithelium (RPE) which can age at different rates. Other established or putative AMD risk factors can differentially affect the neuroretina and RPE and can differently interplay with aging of these structures. The occurrence of β-amyloid plaques and increased levels of cholesterol in AMD retinas suggest that AMD may be a syndrome of accelerated brain aging. Therefore, the question about the real meaning of age in AMD is justified. In this review we present and update information on how aging may interplay with some aspects of AMD pathogenesis, such as oxidative stress, amyloid beta formation, circadian rhythm, metabolic aging and cellular senescence. Also, we show how this interplay can be specific for photoreceptors, microglia cells and RPE cells as well as in Bruch's membrane and the choroid. Therefore, the process of aging may differentially affect different retinal structures. As an accurate quantification of biological aging is important for risk stratification and early intervention for age-related diseases, the determination how photoreceptors, microglial and RPE cells age in AMD may be helpful for a precise diagnosis and treatment of this largely untreatable disease.

Keywords: Age-related macular degeneration; Biological aging; Cellular senescence; Chronological aging; Circadian rhythm; Metabolic aging; Microglia; Neural retina; Retinal pigment epithelium.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / pathology
  • Amyloid beta-Peptides* / metabolism
  • Bruch Membrane / metabolism
  • Bruch Membrane / pathology
  • Humans
  • Macular Degeneration* / metabolism
  • Retinal Pigment Epithelium / metabolism

Substances

  • Amyloid beta-Peptides